The company is a medical devices company that has developed a novel diagnostic test to determine breast cancer risk. The company’s test uses breast fluid to analyze the presence of normal, pre-malignant and malignant cells. Unlike traditional tests that detect cell tumor lumps in the breast when cancer has advanced into a mature state, this test can detect cancer risk years before tumor build up. The test is a non-invasive, 5 minute procedure that is fully automated and can be used in busy primary care settings, yet still provides doctors with advanced diagnostic results.
NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19